Mounjaro / Zepbound (Tirzepatide)

Description

Effective Treatment for Type 2 Diabetes and Weight Management

Mounjaro / Zepbound (Tirzepatide) is an injectable medication used to manage type 2 diabetes and support weight loss. It combines the action of two natural hormones, GIP and GLP-1, to help lower blood sugar levels and reduce appetite. By targeting multiple pathways in the body, Tirzepatide offers a comprehensive approach to controlling blood glucose and supporting weight management.

Mounjaro is available in 2.5 mg/0.6 ml, 5 mg/0.6 ml, 7.5 mg/0.6 ml, 10 mg/0.6 ml, 12.5 mg/0.6 ml, and 15 mg/0.6 ml dosages, providing flexible treatment options for patients.

Why Choose Mounjaro / Zepbound?

• Dual Hormonal Action: Combines the benefits of GIP and GLP-1 to control blood sugar and reduce appetite.

• Proven Efficacy: Reduces HbA1c levels and supports significant weight loss.

• Once-Weekly Dosing: Administered via KwikPen once a week for convenience.

• Flexible Dosing: Available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses for personalized treatment.

Common Usage & Dosage

Mounjaro / Zepbound is typically administered as a once-weekly subcutaneous injection using the KwikPen. The dosage starts at 2.5 mg/0.6 ml and is gradually increased based on the patient’s needs, with doses available up to 15 mg/0.6 ml.